Human Lupus Nephritis and Tubulointerstitial Inflammation in In
Total Page:16
File Type:pdf, Size:1020Kb
In Situ B Cell-Mediated Immune Responses and Tubulointerstitial Inflammation in Human Lupus Nephritis This information is current as Anthony Chang, Scott G. Henderson, Daniel Brandt, Ni Liu, of September 26, 2021. Riteesha Guttikonda, Christine Hsieh, Natasha Kaverina, Tammy O. Utset, Shane M. Meehan, Richard J. Quigg, Eric Meffre and Marcus R. Clark J Immunol 2011; 186:1849-1860; Prepublished online 27 December 2010; Downloaded from doi: 10.4049/jimmunol.1001983 http://www.jimmunol.org/content/186/3/1849 Supplementary http://www.jimmunol.org/content/suppl/2010/12/27/jimmunol.100198 http://www.jimmunol.org/ Material 3.DC1 References This article cites 85 articles, 21 of which you can access for free at: http://www.jimmunol.org/content/186/3/1849.full#ref-list-1 Why The JI? Submit online. by guest on September 26, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2011 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology In Situ B Cell-Mediated Immune Responses and Tubulointerstitial Inflammation in Human Lupus Nephritis Anthony Chang,*,1 Scott G. Henderson,†,1 Daniel Brandt,† Ni Liu,† Riteesha Guttikonda,† Christine Hsieh,† Natasha Kaverina,† Tammy O. Utset,† Shane M. Meehan,* Richard J. Quigg,‡ Eric Meffre,x and Marcus R. Clark† The most prevalent severe manifestation of systemic lupus erythematosus is nephritis, which is characterized by immune complex deposition, inflammation, and scarring in glomeruli and the tubulointerstitium. Numerous studies indicated that glomerulonephritis results from a systemic break in B cell tolerance, resulting in the local deposition of immune complexes containing Abs reactive with ubiquitous self-Ags. However, the pathogenesis of systemic lupus erythematosus tubulointerstitial disease is not known. In this article, we demonstrate that in more than half of a cohort of 68 lupus nephritis biopsies, the tubulointerstitial infiltrate was or- ganized into well-circumscribed T:B cell aggregates or germinal centers (GCs) containing follicular dendritic cells. Sampling of the Downloaded from in situ-expressed Ig repertoire revealed that both histological patterns were associated with intrarenal B cell clonal expansion and ongoing somatic hypermutation. However, in the GC histology, the proliferating cells were CD1382CD20+ centroblasts, whereas they were CD138+CD20low/2 plasmablasts in T:B aggregates. The presence of GCs or T:B aggregates was strongly associated with tubular basement membrane immune complexes. These data implicate tertiary lymphoid neogenesis in the pathogenesis of lupus tubulointerstitial inflammation. The Journal of Immunology, 2011, 186: 1849–1860. http://www.jimmunol.org/ he clinical manifestations of systemic lupus erythematosus renal manifestation most clearly related to the central pathogenic (SLE) are myriad and range from mild arthralgias and skin feature of SLE: systemic loss of B cell tolerance (1, 7, 8). T rashes to life-threatening nephritis (1). Patients with focal The presence of serum anti-dsDNA Abs identifies lupus patients or diffuse proliferative lupus nephritis (LN) have a more rapidly at increased risk for GN, whereas increasing titers of anti-dsDNA progressive disease and require more aggressive treatment than do Abs often herald renal flares in individual SLE patients (1). Anti- those with mesangial proliferative or membranous LN (2). Sig- dsDNA Abs have been isolated from SLE renal biopsies (9, 10), nificant morbidity and mortality are consequences of the nephritis and infusion of some murine and human anti-dsDNA Abs can and the cytotoxic therapeutic regimens used to treat it (3). induce GN in mice (11, 12). Furthermore, recent immunoelectron by guest on September 26, 2021 Pathologically, LN is characterized by immune complex de- microscopic studies directly demonstrated the presence of anti- position and inflammation in glomeruli and the tubulointerstitium dsDNA Ab-containing immune complexes in diseased glomeruli that, if left untreated, can result in scarring and irreversible organ (13, 14). These observations led to the hypothesis that anti-dsDNA failure. Of the pathological manifestations of LN, glomerulone- IgG Abs play a central role in the pathogenesis of lupus GN. phritis (GN) is the best studied and the feature most often replicat- However, tubulointerstitial inflammation (TI) is also a com- ed in murine models of autoimmune disease (4–6). GN is also the mon feature of LN (15–17) (C. Hsieh, A. Chang, R. Guttikonda, D. Brandt, T. O. Utset, and M.R. Clark, submitted for publication). On renal biopsy, the presence and degree of TI identify those *Department of Pathology, University of Chicago, Chicago, IL 60637; patients with LN who are at risk for progression to renal failure † Section of Rheumatology, Department of Medicine and Knapp Center for Lupus (15, 16) (C. Hsieh et al., submitted for publication). In contrast, Research, University of Chicago, Chicago, IL 60637; ‡Section of Nephrology, De- partment of Medicine, University of Chicago, Chicago, IL 60637; and xDepartment the National Institutes of Health activity index, which primarily of Rheumatology, Hospital for Special Surgery, Cornell University, New York, NY assesses glomerular inflammation, does not correlate with prog- 10021 nosis (15, 18, 19). Furthermore, the presence of tubulointerstitial 1 A.C. and S.G.H. contributed equally to this work. scarring on renal biopsy is more predictive of subsequent renal Received for publication June 16, 2010. Accepted for publication November 23, failure than is glomerular scarring (15, 16) (C. Hsieh et al., sub- 2010. mitted for publication). TI can occur independently of GN (20, This work was supported by grants from the Lupus Research Institute and the 21), and TI severity does not correlate with titers of anti-dsDNA National Institutes of Health (AI082724, AR055646). Abs (C. Hsieh et al., submitted for publication). These data indicate Address correspondence and reprint requests to Dr. Marcus Clark, Section of Rheu- matology, Department of Medicine, University of Chicago, 5841 S. Maryland Ave- that TI is an important manifestation of LN that might arise from nue, Chicago, IL 60637. E-mail address: [email protected] different pathogenic mechanisms from those implicated in GN. The online version of this article contains supplemental material. Organ-specific inflammation is a defining feature of many au- Abbreviations used in this article: FDC, follicular dendritic cell; FWR, framework toimmune diseases, including Hashimoto’s thyroiditis (22), rheu- region; GC, germinal center; GN, glomerulonephritis; IMGT, international ImMuno- matoid arthritis (RA) (23), Sjo¨gren’s syndrome (24), and multiple GeneTics information system; LCM, laser capture microdissection; LN, lupus ne- phritis; R, replacement; RA, rheumatoid arthritis; S, silent; SLE, systemic lupus sclerosis (25). In these diseases, infiltrating lymphocytes are often erythematosus; TBM, tubular basement membrane; TBMIC, tubular basement mem- highly organized and resemble lymphoid structures found in sec- brane immune complex; TI, tubulointerstitial inflammation; TLN, tertiary lymphoid ondary lymphoid organs during a normal immune response. This neogenesis. feature is referred to as tertiary lymphoid neogenesis (TLN). Copyright Ó 2011 by The American Association of Immunologists, Inc. 0022-1767/11/$16.00 B cells within these lymphoid structures secrete autoantibodies www.jimmunol.org/cgi/doi/10.4049/jimmunol.1001983 1850 IN SITU IMMUNE RESPONSES IN LUPUS NEPHRITIS (26, 27) and are required to locally maintain activated T cells Laser capture microdissection of interstitial CD38+ or Ki-67+ (28). Several reports noted that infiltrating T cells are a prom- cells inent feature of LN (29–33), whereas the presence of B cells At the time of procurement, renal biopsies were immediately frozen in OCT was recently noted (34–36). However, the significance of these media (Tissue-Tek, Torrance, CA) and stored at 280˚C. These consisted of lymphocyte populations in the interstitial infiltrate was unclear. 10 kidney biopsies from 10 patients. Patients A, B, C, D, and F were In this article, we demonstrate that in moderate or severe TI the females (23–40 y of age; one white, three African American, and one inflammatory infiltrates are usually organized into structures re- Hispanic) with established diagnoses of SLE from 4 mo to 10 y who were treated with low doses of prednisone prior to kidney biopsy. Patients E, G, miniscent of those observed in secondary lymphoid organs. Most H, and J were females (13–37 y of age; three African American and one commonly, aggregates of T and B cells containing plasmablasts Hispanic) with new-onset SLE and no significant immunosuppressive were observed. However, in some renal biopsies there were ger- therapy prior to renal biopsy. Patient I was